ES2104841T3 - Fosfono-aminoacidos bencimidazolicos. - Google Patents

Fosfono-aminoacidos bencimidazolicos.

Info

Publication number
ES2104841T3
ES2104841T3 ES92309160T ES92309160T ES2104841T3 ES 2104841 T3 ES2104841 T3 ES 2104841T3 ES 92309160 T ES92309160 T ES 92309160T ES 92309160 T ES92309160 T ES 92309160T ES 2104841 T3 ES2104841 T3 ES 2104841T3
Authority
ES
Spain
Prior art keywords
bencimidazolic
phosphone
hydrogen
compounds
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92309160T
Other languages
English (en)
Inventor
Reinhardt Bernhard Baudy
III Horace FLETCHER
John Patrick Yardley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2104841T3 publication Critical patent/ES2104841T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Insulating Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

LOS COMPUESTOS DE LA FORMULA EN DONDE R ES HIDROGENO, ALQUILO INFERIOR, BENCILO O PIVALOILOXIMETILO; R1 Y R2 SON, INDEPENDIENTEMENTE, HIDROGENO, ALQUILO INFERIOR, ALCOXI INFERIOR, TRIFLUOMETILO, TRIFLUOMETOXI, METANOSULFONILAMINO, ACETILAMNINO O HALO CUANDO R1 Y R2 JUNTOS REPRESENTAN UNA AGRUPACION METILENODIOXI; A LAS SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS MISMOS, SON ANTAGONISTAS DE NMDA UTILES EN EL TRATAMIENTO Y PREVENCION DE CONDICIONES PATOLOGICAS RELACIONADAS CON EL SISTEMA NERVIOSO CENTRAL RESULTANTES DE LA SOBREESTIMULACION PROVOCADA POR AMINOACIDOS EXCITANTES. TAMBIEN SE PRESENTAN LOS PROCESOS PARA LA PREPARACION DE LOS COMPUESTOS Y LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES92309160T 1991-10-11 1992-10-08 Fosfono-aminoacidos bencimidazolicos. Expired - Lifetime ES2104841T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/776,528 US5124319A (en) 1991-10-11 1991-10-11 Benzimidazole phosphono-amino acids

Publications (1)

Publication Number Publication Date
ES2104841T3 true ES2104841T3 (es) 1997-10-16

Family

ID=25107643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92309160T Expired - Lifetime ES2104841T3 (es) 1991-10-11 1992-10-08 Fosfono-aminoacidos bencimidazolicos.

Country Status (22)

Country Link
US (1) US5124319A (es)
EP (1) EP0539057B1 (es)
JP (1) JPH05222077A (es)
KR (1) KR930007961A (es)
AT (1) ATE155473T1 (es)
AU (1) AU656811B2 (es)
CA (1) CA2080253A1 (es)
CZ (1) CZ308392A3 (es)
DE (1) DE69220879T2 (es)
DK (1) DK0539057T3 (es)
ES (1) ES2104841T3 (es)
FI (1) FI924570A7 (es)
GR (1) GR3024767T3 (es)
HU (2) HUT62196A (es)
IL (1) IL103330A (es)
MX (1) MX9205816A (es)
NO (1) NO300690B1 (es)
NZ (1) NZ244587A (es)
RU (1) RU2073004C1 (es)
SG (1) SG47768A1 (es)
SK (1) SK279381B6 (es)
ZA (1) ZA927535B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334618A (en) * 1991-04-04 1994-08-02 The Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
US5124319A (en) * 1991-10-11 1992-06-23 American Home Products Corporation Benzimidazole phosphono-amino acids
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
IS4233A (is) * 1993-12-22 1995-06-23 Astra Aktiebolag Misleit hringtengd efnasambönd
US5864040A (en) * 1996-01-11 1999-01-26 American Home Products Corporation Benzimidazole phosphono-amino acids
WO1998039344A1 (en) * 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
DE69819311T2 (de) * 1997-03-07 2004-07-29 Metabasis Therapeutics Inc., San Diego Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
US6316474B1 (en) * 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
UA78529C2 (en) * 2001-10-10 2007-04-10 Wyeth Corp Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
AU2004229567A1 (en) * 2003-04-09 2004-10-28 Wyeth Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof
WO2004092189A1 (en) * 2003-04-09 2004-10-28 Wyeth Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
US20050142192A1 (en) * 2003-10-15 2005-06-30 Wyeth Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
TW200514775A (en) * 2003-10-22 2005-05-01 Wyeth Corp Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
KR20100045983A (ko) 2007-06-29 2010-05-04 에모리 유니버시티 신경보호를 위한 ｎｍｄａ 수용체 길항물질
US20090061024A1 (en) * 2007-08-27 2009-03-05 Wyeth Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU959724A1 (ru) * 1981-05-06 1982-09-23 Ленинградский Ордена Трудового Красного Знамени Сельскохозяйственный Институт Способ регулировани роста растений огурца
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives
US4746653A (en) * 1986-02-28 1988-05-24 Ciba-Geigy Corporation Certain hetero phosphonic acid derivatives of 2-piperidine or 2-tetrahydropyridinecarboxylates and esters thereof which are useful for the treatment of disorders responsive to blockade of the NMDA receptor in mammals
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
US5124319A (en) * 1991-10-11 1992-06-23 American Home Products Corporation Benzimidazole phosphono-amino acids

Also Published As

Publication number Publication date
FI924570L (fi) 1993-04-12
HU211942A9 (en) 1996-01-29
ZA927535B (en) 1994-03-30
NZ244587A (en) 1994-04-27
RU2073004C1 (ru) 1997-02-10
SK279381B6 (sk) 1998-10-07
NO923940L (no) 1993-04-13
KR930007961A (ko) 1993-05-20
EP0539057B1 (en) 1997-07-16
GR3024767T3 (en) 1997-12-31
AU2626992A (en) 1993-04-22
IL103330A0 (en) 1993-03-15
FI924570A7 (fi) 1993-04-12
SG47768A1 (en) 1998-04-17
CZ308392A3 (en) 1993-08-11
SK308392A3 (en) 1995-02-08
NO923940D0 (no) 1992-10-09
DK0539057T3 (da) 1998-02-09
NO300690B1 (no) 1997-07-07
AU656811B2 (en) 1995-02-16
DE69220879T2 (de) 1997-11-20
EP0539057A1 (en) 1993-04-28
HUT62196A (en) 1993-04-28
FI924570A0 (fi) 1992-10-09
CA2080253A1 (en) 1993-04-12
DE69220879D1 (de) 1997-08-21
HU9203203D0 (en) 1992-12-28
JPH05222077A (ja) 1993-08-31
IL103330A (en) 1996-10-31
MX9205816A (es) 1993-07-01
US5124319A (en) 1992-06-23
ATE155473T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
ES2121896T3 (es) Derivados de acido hidroxamico como inhibidores de colagenasa.
MX9305379A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene.
ES2093399T3 (es) Nuevos derivados de acido fosfono-succinico, procedimiento para su preparacion y medicamentos que contienen estos compuestos.
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
ES2152444T3 (es) Derivados de acido benzazepin-, benzoxazepin- y benzotiazepin-n-acetico, asi como procedimiento para su preparacion y medicamentos que contienen a estos compuestos.
MX9206474A (es) Derivados de n-fenilalanil y n-fenilgliclil del dipeptido del acido l-azetidina 2-carboxilico y aldheido de l-arginina, proceso para su preparacion y composicion farmaceutica que los contiene
MX9205816A (es) Acidos benzimidazolfosfono-amino y proceso para su preparacion.
MX9301197A (es) Derivados de indol.
ES2071666T3 (es) Derivados de pirazoloisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9602979A (es) Compuestos heterociclicos terapeuticos.
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
PT96030A (pt) Processo para a preparacao de aminocarbonilcarbamatos relacionados com fisoestigmina e de composicoes farmaceuticas que os contem
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
ES2102870T3 (es) Benzopiranos y composiciones farmaceuticas que los contienen.
MX9603272A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
ES2183492T3 (es) Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT1234818E (pt) Sais de calcio de derivados de 1,5-benzodiazepina, processo para producao dos sais e drogas que os contem
ES2064361T3 (es) Nuevos compuestos.
MX9300306A (es) Bencimidazoles medicamentos que contienen estos compuestos y procedimiento para su preparacion.
JPS6466116A (en) Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 539057

Country of ref document: ES